Possible Divergent Local and Peripheral Immunological Effects of Low-Dose Mesencure, an Enhanced Mesenchymal Cell Therapy, May Contribute to Its Success in Treating Severe Covid-19 Patients

MesenCure (adipose tissue derived activated mesenchymal stromal cells) - Wize Pharma, Bonus BioGroup

https://eventpilot.us/web/page.php?page=Session&project=ASH21&id=147743

Tomer Bronshtein, PhD1; Dror Ben David, PhD2; Atara Novak, PhD2; Vered Kivity, PhD2; Shai Meretzki, PhD2; Tony Hayek, MD3; Shadi Hamoud, MD3; Nimrod Rozen, MD, Ph.D4

Nov 5, 2021